Corticosteroid inhalers for copd

Teva Pharmaceutical Industries Ltd.  (NYSE and TASE: TEVA) is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions used by millions of patients every day. Headquartered in Israel, Teva is the world’s largest generic medicines producer, leveraging its portfolio of more than 1,800 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has a world-leading position in innovative treatments for disorders of the central nervous system, including pain, as well as a strong portfolio of respiratory products. Teva integrates its generics and specialty capabilities in its global research and development division to create new ways of addressing unmet patient needs by combining drug development capabilities with devices, services and technologies. Teva's net revenues in 2015 were $ billion. For more information, visit  .

Corticosteroid inhalers for copd

corticosteroid inhalers for copd

Media:

corticosteroid inhalers for copdcorticosteroid inhalers for copdcorticosteroid inhalers for copdcorticosteroid inhalers for copdcorticosteroid inhalers for copd